MedTrace Logo

Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers

NCT00711776 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-08-31

No results posted yet for this study

Summary

This study is designed to show bioequivalence between Current and New formulation of Aciclovir cream 5% in keratin layer of the epidermis in Japanese Subjects

Conditions

  • Herpes Labialis

Interventions

DRUG

New formulation

New formulation of Aciclovir Cream 5% scheduled to be substituted to Current formulation in Japan

DRUG

Current formulation

Current formulation of Aciclovir Cream 5% in Japan

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-10
Primary Completion
2008-08-17
Completion
2008-08-17

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00711776 on ClinicalTrials.gov